Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Healthy Returns

Recent news which mentions Healthy Returns

< Previous 1 2 Next >
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care industry
From CNBC.com News
Healthy Returns: What to know about Trump's NIH funding cuts
Tags Health care industry Biotech and Pharmaceuticals Health & Science
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags Healthy Returns Social issues Health & Science
From CNBC.com News
Healthy Returns: Trump made sweeping changes to health care in his first week
Tags Health & Science Government and politics Healthy Returns
From CNBC.com News
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Tags Health & Science Johnson & Johnson Healthy Returns
From CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
Tags Moderna Inc Merck & Co Inc Madrigal Pharmaceuticals Inc
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
Tags BridgeBio Pharma Inc Bristol/Myers Squibb Co Healthy Returns
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Social issues Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Social issues Healthy Returns LILLY DRN
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Bristol/Myers Squibb Co Healthy Returns AstraZeneca PLC
From CNBC.com News
Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say
Tags Healthy Returns Biotech and Pharmaceuticals Social issues
From CNBC.com News
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
Tags Biotech and Pharmaceuticals Amgen Inc Health care industry
From CNBC.com News
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
Tags Social issues AstraZeneca PLC Healthy Returns
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Viking Therapeutics Inc
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Biotech and Pharmaceuticals Novo Nordisk A/S UnitedHealth Group Inc
From CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Social issues Healthy Returns Science
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags Social issues Novo Nordisk A/S Abbott Laboratories
From CNBC.com News
Healthy Returns: What activist Starboard's $1 billion stake means for Pfizer
Tags Health & Science Healthy Returns Hims & Hers Health Inc
From CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
Tags Fulcrum Therapeutics Inc Health care industry UnitedHealth Group Inc
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Tags Health & Science Health care industry Healthy Returns
From CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Tags Healthy Returns Eli Lilly and Co Social issues
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
Tags Health & Science Healthy Returns Apple Inc
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
Tags Health care industry Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines
Tags Health care industry Pfizer Inc Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: The race to develop combination shots targeting Covid, flu is heating up
Tags Health care industry Sanofi SA Pfizer Inc
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Novartis AG Breaking News: Politics Politics
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Healthy Returns Altimmune Inc Augmedix Inc
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Healthy Returns AstraZeneca PLC Novartis AG
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Healthy Returns Eli Lilly and Co Health & Science
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.